Outcome of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Beyond First Complete Remission (CR1)

被引：8

作者：

Evers, Georg ^{[1
]}

Beelen, Dietrich W. ^{[2
]}

Braess, Jan ^{[3
]}

Sauerland, Cristina ^{[4
]}

Kolb, Hans-Jochem ^{[5
]}

Reichle, Albrecht ^{[6
]}

Holler, Ernst ^{[6
]}

Schwerdtfeger, Rainer ^{[7
]}

Arnold, Renate ^{[8
]}

Scheid, Christoph ^{[9
,10
]}

Krug, Utz ^{[11
]}

Mueller-Tidow, Carsten ^{[12
]}

Schliemann, Christoph ^{[13
]}

Mikesch, Jan-Henrik ^{[14
]}

Lenz, Georg ^{[15
]}

Woermann, Bernhard J. ^{[8
]}

Hiddemann, Wolfgang ^{[5
]}

Berdel, Wolfgang E. ^{[14
]}

Stelljes, Matthias ^{[14
]}

机构：

[1] Univ Hosp Munster, Dept Internal Med Hematol & Oncol A, Munster, Germany

[2] Univ Hosp Essen, West German Canc Ctr, Dept Bone Marrow Transplantat, Essen, Germany

[3] Krankenhaus Barmherzige Brueder, Regensburg, Germany

[4] Univ Munster, Inst Biostat & Clin Res, Munster, Germany

[5] Ludwig Maximilians Univ Hosp Munich, Dept Med 3, Munich, Germany

[6] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany

[7] Deutsch Klin Diagnost Helios Klin, Ctr Hematopoiet Cell Transplantat, Wiesbaden, Germany

[8] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[9] Univ Cologne, Dept Internal Med 1, Cologne, Germany

[10] Univ Cologne, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany

[11] Klinikum Leverkusen, Dept Med 3, Leverkusen, Germany

[12] Univ Hosp Heidelberg, Dept Internal Med 5, Heidelberg, Germany

[13] Univ Klinikum Munster, Med Klin A, Munster, Germany

[14] Univ Hosp Muenster, Dept Med A, Munster, Germany

[15] Univ Hosp Munster, Munster, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-116964

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4649

引用

页数：4

共 50 条

[1] Allogeneic hematopoietic stem cell transplantation (HSCT) beyond first complete remission (CR) in patients with acute myeloid leukemia (AML): Results from the AMLCG1999 trial
Evers, G.
Beelen, D. W.
Braess, J.
Sauerland, M. C.
Kolb, H. J.
Reichle, A.
Holler, E.
Schwerdtfeger, R.
Arnold, R.
Scheid, C.
Krug, U.
Mueller-Tidow, C.
Schliemann, C.
Mikesch, J. -H.
Lenz, G.
Woermann, B. J.
Hiddemann, W.
Berdel, W. E.
Stelljes, M.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 117 - 118
[2] Treatment of acute myeloid leukemia (AML) in first remission (CR1) with unrelated donor (UD) allogeneic hematopoietic cell transplantation (HCT).
Bashir, Q.
Andersson, B.
De Padua Silva, L.
Rondon, G.
Chiattone, A.
Hosing, C.
Fernandez-Vina, M.
Giralt, S.
Champlin, R. E.
De Lima, M. J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[3] Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) Not in First Remission
Sweet, Kendra L.
Lancet, Jeffrey E.
Hillgruber, Ryan
Melody, Megan
Llishi, Amina
Perkins, Janelle
Fernandez, Hugo F.
Field, Teresa
BLOOD, 2015, 126 (23)
[4] Reduced intensity conditioning (RIC) prior to allogeneic stem cell transplantation (SCT) for patients (PTS) with acute myeloid leukemia (AML) in first complete remission (CR1)
Vey, N.
Boiron, J. M.
Faucher, C.
Mohty, M.
Bay, J. O.
Bardoux, V. J.
Perreau, V
Coso, D.
Pigneux, A.
Blaise, D.
ANNALS OF HEMATOLOGY, 2006, 85 : 27 - 27
[5] Sex-associated outcome differences in patients (pts) with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (HSCT)
Ussmann, J.
Bischof, L.
Backhaus, D.
Brauer, D.
Pointner, R.
Franke, G. -N
Vucinic, V.
Merz, M.
Platzbecker, U.
Schwind, S.
Jentzsch, M.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 195 - 195
[6] HLA-Matched Sibling Versus Haploidentical Hematopoietic Cell Transplantation (HCT) in Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
Rashidi, Armin
Hamadani, Mehdi
Wang, Hai-Lin
Bolanos, Javier
Lee, Jong Wook
Ciurea, Stefan O.
Holland, H. Kent
Koc, Yener
Maertens, Johan A.
Stockerl-Goldstein, Keith
Bashey, Asad
Aljurf, Mahmoud
Cutler, Corey
Nakamura, Ryotaro
Oran, Betul
Shaffer, Brian C.
Hahn, Theresa E.
de Lima, Marcos
Sandmaier, Brenda M.
Litzow, Mark R.
Weisdorf, Daniel J.
Zhang, Mei-Jie
Romee, Rizwan
Saber, Wael
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[7] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)
Lipof, Jodi J.
Manogna, Dharmini
Baran, Andrea M.
Said, Bassil
Becker, Michael W.
Mendler, Jason H.
Aljitawi, Omar S.
O'Dwyer, Kristen Marie
Huselton, Eric
Burack, Richard
Blaney, Margaret
Douglas, Taylor
Liesveld, Jane L.
Loh, Kah Poh
BLOOD, 2020, 136
[8] Impact of Donor Age on Outcome of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation in Complete Remission
Hemmati, Philipp
Terwey, Theis
Na, Il-Kang
Jehn, Christian
Vuong, Lam
le Coutre, Philipp
Doerken, Bernd
Arnold, Renate
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S203 - S203
[9] Stem Cell Transplantation in Elderly Patients with Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR1)
Arnold, Renate
Beelen, Dietrich
Bornhaeuser, Martin
Bunjes, Donald
Finke, Juergen
Kroeger, Nikolaus
Stadler, Michael
Stelljes, Matthias
Goekbuget, Nicola
Hoelzer, Dieter
BLOOD, 2008, 112 (11) : 686 - 686
[10] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for the Treatment of Children with Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) In First Remission (CR1)
Boulad, Farid
Kernan, Nancy A.
Steinherz, Peter G.
Prockop, Susan E.
Scaradavou, Andromachi
Small, Trudy N.
Kobos, Rachel
Shukla, Neerav
Doorish, Carolyn
O'Reilly, Richard J.
BLOOD, 2010, 116 (21) : 1458 - 1459

← 1 2 3 4 5 →